Cargando…
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
BACKGROUND AND AIM: As a result of its rapid spread in various countries around the world, on March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 status from epidemic to pandemic disease. The virus that causes this disease is indicated originating from animals traded...
Autores principales: | Astuti, Indwiani, Ysrafil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165108/ https://www.ncbi.nlm.nih.gov/pubmed/32335367 http://dx.doi.org/10.1016/j.dsx.2020.04.020 |
Ejemplares similares
-
The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review
por: Rizkita, Leonny Dwi, et al.
Publicado: (2021) -
Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
por: Ysrafil, Ysrafil, et al.
Publicado: (2022) -
Corrigendum to “The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review” [J. Pharma. Anal. 11 (2021) 265–271]
por: Dwi Rizkita, Leonny, et al.
Publicado: (2022) -
Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression
por: Ysrafil, Ysrafil, et al.
Publicado: (2022) -
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: O’Leary, Valerie Bríd, et al.
Publicado: (2020)